Your browser doesn't support javascript.
loading
Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials.
Li, Mengnan; Zhang, Jian; Yang, Guimei; Zhang, Jiaxin; Han, Minmin; Zhang, Yi; Liu, Yunfeng.
Afiliação
  • Li M; Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Zhang J; First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
  • Yang G; Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Zhang J; First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
  • Han M; Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Zhang Y; First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
  • Liu Y; Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, China.
Eur J Clin Pharmacol ; 79(6): 859-871, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37097298

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Eur J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Eur J Clin Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China